DrugPatentWatch Database Preview
Drugs in Development Information for Sirna-027
Summary for Sirna-027
| US Patents | 2 |
| International Patents | 248 |
| US Patent Applications | 0 |
| WIPO Patent Applications | 0 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (2016-01-01) |
| Vendors | 0 |
US Patents for Sirna-027
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Sirna-027 | ➤ Sign Up | Compositions and methods to control angiogenesis with cupredoxins | The Board of Trustees of the University of Illinois (Urbana, IL) | ➤ Sign Up |
| Sirna-027 | ➤ Sign Up | Recombinant vectors | Tocagen Inc. (San Diego, CA) | ➤ Sign Up |
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
International Patents for Sirna-027
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Sirna-027 | Austria | 470672 | 2023-08-15 | ➤ Sign Up |
| Sirna-027 | Australia | 2002311753 | 2021-02-15 | ➤ Sign Up |
| Sirna-027 | Australia | 2004266632 | 2021-02-15 | ➤ Sign Up |
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
